Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does losartan alter urinary levels of connective tissue growth factor in patients with diabetic nephropathy?

Nature Clinical Practice Nephrology volume 2, pages 192–193 (2006)Cite this article

boxed-textAndersen S et al. (2005) Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy. Kidney Int 67: 2325–2329

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Suzuki H (2004) Angiotensin type 1 receptor blockers in chronic kidney disease. Contrib Nephrol 143: 159–166

    Article  Google Scholar 

  2. Inigo P et al. (2001) Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-[beta]1 plasma levels in a crossover trial in renal transplant recipients. J Am Soc Nephrol 12: 822–827

    CAS  PubMed  Google Scholar 

  3. Perico N et al. (2004) Losartan in diabetic nephropathy. Expert Rev Cardiovasc Ther 2: 473–483

    Article  CAS  Google Scholar 

  4. Lewis EJ et al. (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456–1462

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Renal Transplant Unit at the Hospital Clinic, University of Barcelona, Spain

    Josep M Campistol

Authors
  1. Josep M Campistol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josep M Campistol.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Campistol, J. Does losartan alter urinary levels of connective tissue growth factor in patients with diabetic nephropathy?. Nat Rev Nephrol 2, 192–193 (2006). https://doi.org/10.1038/ncpneph0152

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0152

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing